Advanced Biomed Inc.
ADVB
$0.60
$0.1431.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 90.96% | 81.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 58.97% | 45.08% | |||
| Operating Income | -58.97% | -45.08% | |||
| Income Before Tax | 49.30% | -52.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 49.30% | -52.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.30% | -52.43% | |||
| EBIT | -58.97% | -45.08% | |||
| EBITDA | -67.70% | -60.44% | |||
| EPS Basic | 52.07% | -48.90% | |||
| Normalized Basic EPS | 51.90% | -48.59% | |||
| EPS Diluted | 52.07% | -48.90% | |||
| Normalized Diluted EPS | 51.90% | -48.59% | |||
| Average Basic Shares Outstanding | 5.64% | 2.40% | |||
| Average Diluted Shares Outstanding | 5.64% | 2.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||